KYAN Therapeutics


KYAN Therapeutics is a clinical-stage AI biotechnology company that utilizes proprietary technology to transform the way patients are treated and how therapies are developed. Our clinically-validated platforms revolutionize drug development by de-risking and dramatically accelerating the process at a fraction of the cost of traditional models. Our platform integrates proprietary arrays, automated experimentation and AI to drive combination therapy development, media culturing, clinical stratification and dosage recommendation.







For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738